FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4255989757> ?p ?o ?g. }

• W4255989757 endingPage "S169" @default.
• W4255989757 startingPage "S168" @default.
• W4255989757 abstract "Introduction: Endoscopic therapy, the current treatment of choice for BE patients with HGD, is also a noninvasive alternative to surgery for treatment of BE with intra-mucosal cancer (IMC). There are limited data comparing the outcomes of endoscopic therapy in BE patients with IMC and HGD. We aimed to compare the rates of complete eradication of intestinal metaplasia (CE-IM), complete eradication of dysplasia (CE-D) and recurrent IM (Re-IM) between the two groups -IMC and HGD.Table: Table. Baseline characteristics and outcomes of endoscopic therapy in IMC and HGDMethods: We reviewed all BE subjects with HGD and IMC who underwent endoscopic therapy in a multicenter prospective registry. Patients were treated with endoscopic mucosal resection if visible lesions were noted and/or mucosal ablation (RFA, cryotherapy, APC) for the flat BE. Patients who underwent at least four EGDs with endoscopic therapy were included in the study. CEIM and CED was defined as histologic absence of intestinal metaplasia (IM) and dysplasia respectively. Re-IM was defined as histologic evidence of BE (IM, dysplasia or esophageal adenocarcinoma (EAC)) after achieving CEIM. Rates of CEIM, CED and Re-IM were calculated for the two study groups - IMC and HGD. Cox proportional hazard models were used to compare the outcomes of endoscopic therapy between the two groups. Results: 276 subjects (70 with IMC and 206 with HGD) with BE who underwent endoscopic therapy were included in the study. The median (IQR) age was 66.0 (58.0, 73.0) years. 232 (84.1%) were males. There were no differences in baseline characteristics (age, sex and BE segment length) between the IMC and HGD groups (table 1). In the IMC group, 57 (81.4%) and 62 (88.6%) subjects achieved CE-IM and CE-D respectively. In the HGD group, 173 (84.0%) and 185 (89.8%) subjects achieved CE-IM and CE-D respectively. There was no statistical difference in the proportion of subjects who achieved CE-IM (P=0.62) and CE-D (P=0.77) in the two groups. On multivariate analysis adjusting for age, sex and BE length, there was no statistical difference in the CE-IM (IMC vs HGD; HR 1.15, 95% CI 0.38 - 3.51, P=0.81) and CE-D (IMC vs HGD; HR 1.21, 95% CI 0.31-4.66, P=0.79) rates between the two groups. There were 25 (43.9%) Re-IM in the IMC group and 60 (34.7%) Re-IM in the HGD group (P=0.21). Conclusion: In this large well-defined cohort of BE patients, effectiveness of endoscopic therapy in IMC is comparable to that of HGD. Consideration of endoscopic therapy in BE patients with early cancer could reduce the need for invasive surgery." @default.
• W4255989757 created "2022-05-12" @default.
• W4255989757 creator A5027060776 @default.
• W4255989757 creator A5027560115 @default.
• W4255989757 creator A5047719803 @default.
• W4255989757 creator A5047915584 @default.
• W4255989757 creator A5052084689 @default.
• W4255989757 creator A5052730240 @default.
• W4255989757 creator A5056998508 @default.
• W4255989757 creator A5059989236 @default.
• W4255989757 creator A5066123691 @default.
• W4255989757 creator A5073067467 @default.
• W4255989757 creator A5074462694 @default.
• W4255989757 creator A5078966020 @default.
• W4255989757 creator A5079464849 @default.
• W4255989757 creator A5081284774 @default.
• W4255989757 creator A5084236193 @default.
• W4255989757 creator A5084479948 @default.
• W4255989757 creator A5088448743 @default.
• W4255989757 creator A5090429461 @default.
• W4255989757 date "2017-10-01" @default.
• W4255989757 modified "2023-09-30" @default.
• W4255989757 title "Effectiveness of Endoscopic Therapy in Patients With Barrettʼs Esophagus (BE) With Early Cancer Is Comparable to That of BE With High-Grade Dysplasia (HGD): Results From an International, Multi-center Consortium: 2017 Category Award (Esophagus)" @default.
• W4255989757 doi "https://doi.org/10.1038/ajg.2017.299" @default.
• W4255989757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28981062" @default.
• W4255989757 hasPublicationYear "2017" @default.
• W4255989757 type Work @default.
• W4255989757 citedByCount "1" @default.
• W4255989757 countsByYear W42559897572020 @default.
• W4255989757 crossrefType "journal-article" @default.
• W4255989757 hasAuthorship W4255989757A5027060776 @default.
• W4255989757 hasAuthorship W4255989757A5027560115 @default.
• W4255989757 hasAuthorship W4255989757A5047719803 @default.
• W4255989757 hasAuthorship W4255989757A5047915584 @default.
• W4255989757 hasAuthorship W4255989757A5052084689 @default.
• W4255989757 hasAuthorship W4255989757A5052730240 @default.
• W4255989757 hasAuthorship W4255989757A5056998508 @default.
• W4255989757 hasAuthorship W4255989757A5059989236 @default.
• W4255989757 hasAuthorship W4255989757A5066123691 @default.
• W4255989757 hasAuthorship W4255989757A5073067467 @default.
• W4255989757 hasAuthorship W4255989757A5074462694 @default.
• W4255989757 hasAuthorship W4255989757A5078966020 @default.
• W4255989757 hasAuthorship W4255989757A5079464849 @default.
• W4255989757 hasAuthorship W4255989757A5081284774 @default.
• W4255989757 hasAuthorship W4255989757A5084236193 @default.
• W4255989757 hasAuthorship W4255989757A5084479948 @default.
• W4255989757 hasAuthorship W4255989757A5088448743 @default.
• W4255989757 hasAuthorship W4255989757A5090429461 @default.
• W4255989757 hasConcept C121608353 @default.
• W4255989757 hasConcept C126322002 @default.
• W4255989757 hasConcept C141071460 @default.
• W4255989757 hasConcept C207103383 @default.
• W4255989757 hasConcept C2775894508 @default.
• W4255989757 hasConcept C2776497702 @default.
• W4255989757 hasConcept C2777377203 @default.
• W4255989757 hasConcept C2777819096 @default.
• W4255989757 hasConcept C2778451229 @default.
• W4255989757 hasConcept C2778589982 @default.
• W4255989757 hasConcept C2778866283 @default.
• W4255989757 hasConcept C2778902805 @default.
• W4255989757 hasConcept C2779742542 @default.
• W4255989757 hasConcept C2780149145 @default.
• W4255989757 hasConcept C2781182431 @default.
• W4255989757 hasConcept C44249647 @default.
• W4255989757 hasConcept C71924100 @default.
• W4255989757 hasConcept C90924648 @default.
• W4255989757 hasConceptScore W4255989757C121608353 @default.
• W4255989757 hasConceptScore W4255989757C126322002 @default.
• W4255989757 hasConceptScore W4255989757C141071460 @default.
• W4255989757 hasConceptScore W4255989757C207103383 @default.
• W4255989757 hasConceptScore W4255989757C2775894508 @default.
• W4255989757 hasConceptScore W4255989757C2776497702 @default.
• W4255989757 hasConceptScore W4255989757C2777377203 @default.
• W4255989757 hasConceptScore W4255989757C2777819096 @default.
• W4255989757 hasConceptScore W4255989757C2778451229 @default.
• W4255989757 hasConceptScore W4255989757C2778589982 @default.
• W4255989757 hasConceptScore W4255989757C2778866283 @default.
• W4255989757 hasConceptScore W4255989757C2778902805 @default.
• W4255989757 hasConceptScore W4255989757C2779742542 @default.
• W4255989757 hasConceptScore W4255989757C2780149145 @default.
• W4255989757 hasConceptScore W4255989757C2781182431 @default.
• W4255989757 hasConceptScore W4255989757C44249647 @default.
• W4255989757 hasConceptScore W4255989757C71924100 @default.
• W4255989757 hasConceptScore W4255989757C90924648 @default.
• W4255989757 hasLocation W42559897571 @default.
• W4255989757 hasLocation W42559897572 @default.
• W4255989757 hasOpenAccess W4255989757 @default.
• W4255989757 hasPrimaryLocation W42559897571 @default.
• W4255989757 hasRelatedWork W1893405426 @default.
• W4255989757 hasRelatedWork W1955392013 @default.
• W4255989757 hasRelatedWork W1991643076 @default.
• W4255989757 hasRelatedWork W2032762254 @default.
• W4255989757 hasRelatedWork W2067150613 @default.
• W4255989757 hasRelatedWork W2163518310 @default.
• W4255989757 hasRelatedWork W2741928454 @default.
• W4255989757 hasRelatedWork W2891701670 @default.
• W4255989757 hasRelatedWork W3118357906 @default.
• W4255989757 hasRelatedWork W3122338080 @default.

• next